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Assessing the Effectiveness
of Disease and Injury Prevention Programs:
Costs and Consequences
Summary
Because resources are finite, public health decision makers need to consider
the costs and effectiveness of alternative prevention strategies. A simplified ap-
proach to performing marginal cost-effectiveness analyses requires a) a
description of the program, b) a description of the health outcomes averted and
the timing of those events, c) the rates of the health outcome, d) the preventable
fraction of the health outcomes averted, e) the costs per unit of the intervention,
and f) the direct medical costs of the health outcome prevented and the side
effects incurred. With this information, the marginal cost-effectiveness of an in-
tervention can be determined and applied for decision making.
INTRODUCTION
The assessment of the cost and effectiveness of prevention programs is crucial to
public health activities. The comparison of different preventive and curative strategies
and decisions concerning allocation of finite health resources both depend on obtain-
ing reliable and consistent cost and effectiveness data. This information is used to
document which programs and activities provide the greatest benefit for the funds
expended.
Federal, state, and local health decision makers need to know the costs of preven-
tion programs and the effects of such programs on the health of the populations
targeted for the intervention. To decrease the burden of illness and improve the health
status of the population, resources should be allocated to the extent possible accord-
ing to scientifically determined priorities.
Public health practitioners should provide effective health promotion and protec-
tion programs and return justifiable benefits to their constituents for the resources
consumed. To accomplish these objectives, two questions must be answered: “What
works?” and ”How much does it cost?” 
This report explains how prevention effectiveness methods can be applied in public
health practice and highlights CDC’s mission as the nation’s prevention agency. Pre-
viously published CDC reports examine a basic approach to evaluating available data
to determine the costs and consequences of prevention programs (1–10 ). In these
reports, several prevention strategies were discussed, including water fluoridation
(3), mammography (4 ), control of nosocomial infections (5 ), tractor rollover protec-
tion systems (6 ), smoking cessation (7 ), screening for diabetic-associated eye
disease (8 ), use of bicycle helmets (9 ), and increased physical activity (10 ). Each re-
port included a) the program description; b) the health outcome averted through the
program; c) the current rates and burden of the health outcome; d) the proportion of
this health outcome potentially averted as a result of the program; e) the program
cost; and f) the direct medical treatment cost per prevented health outcome.
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This report provides a basic methodology for calculating and comparing the costs
and consequences of prevention programs. This methodology can assist in making
public health decisions and in setting priorities for prevention strategies.
DEFINITIONS, ASSUMPTIONS, AND ANALYTIC PRINCIPLES
The technique described is used to assess intervention costs and consequences
and is referred to as the Basic Assessment Scheme for Intervention Costs and Conse-
quences methodology (BASICC). It provides a minimum standard for analyzing the
cost-effectiveness of any prevention program. If this analysis is not completed, re-
sources cannot be allocated effectively for the intervention because information
concerning the effects of spending resources are inadequate. Data for this methodol-
ogy should be collected for new programs and for existing programs for which these
data have not been available. A discussion of standards for a comprehensive cost-
effectiveness analysis was published in A Practical Guide to Prevention Effectiveness:
Decision and Economic Analysis (2 ). The following are the underlying principles of
BASICC.
A societal perspective should be used when BASICC principles are applied. The
societal perspective is usually preferred for public health decisions because all re-
sources and benefits associated with the intervention, regardless of who pays for or
who receives them, are included in the analysis. Sometimes, an additional perspective
may be appropriate. Other possible perspectives include that of service providers
(e.g., a clinic, an institution, an agency, or individual providers); business firms; health
insurance companies and health-care reimbursers; government; and program partici-
pants.
Several fundamental terms used in BASICC methodology have been defined in pre-
vious CDC reports (1,2 ). 
Efficacy refers to the scientific basis for “what works” in reducing adverse health
outcomes. It is the improvement in health outcome that a prevention strategy can
produce in expert hands under ideal circumstances. Effectiveness refers to the health
impact of an intervention in typical community settings.
Cost, at a minimum, refers to a) the resources expended in developing, implement-
ing, and maintaining the intervention in a community and b) the health-care resources
saved in avoiding treatment for the health outcomes prevented in the community (i.e.,
direct costs). 
A more complete analysis includes productivity costs and intangible costs. Produc-
tivity costs refer to the cost to an individual and society from the loss of time for
productive pursuits and the value of that time (11 ). Intangible costs (e.g., pain and
suffering) are those for which a monetary value cannot be assigned.
Although all costs associated with prevention resources and benefits should be
included in a complete analysis, BASICC includes only intervention costs and savings
from direct costs. This exclusion of other costs may understate the benefits as well as
the side effects of prevention.
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Net cost calculations enable the costs of a prevention program to be compared
with the medical treatment costs saved from health outcomes averted by the pro-
gram. Net cost, which is defined as
Cost Program  +  Cost Side Effects  −  Cost Health  Outcome  Averted
is the recommended endpoint for BASICC.
The cost of resources needed for a prevention program can be classified as either
fixed or variable. Over a reasonable range of program size, fixed costs do not vary
with the quantity of output (e.g., costs associated with facilities, capital equipment,
and administrative salaries are the same regardless of the number of program cli-
ents). Variable costs change with the level of output and respond proportionately to
change in volume of activity (e.g., provider time and materials increase as the number
of program clients increases). The sum of fixed and variable costs for a specified num-
ber of clients is the total cost of a prevention program.
In cost analyses, average and marginal costs can be calculated. The average cost of
a program, defined as the total cost of the program divided by the total units of output
produced, includes a proportion of rent, utilities, and equipment, even if expansion of
facilities is not required to implement the intervention. Marginal cost is defined as the
additional cost required to produce an additional unit of output. Marginal costs in-
clude only variable costs because of the assumption that, in the short term, an
additional unit of output can be produced with no increase in fixed costs. In BASICC,
marginal costs are considered for interventions that are implemented in preexisting
facilities (i.e., fixed costs associated with providing services are not included). The
average intervention costs are considered for programs that do not use existing facili-
ties or that require expansion of existing facilities. Average costs, however, are not
interchangeable with marginal costs. 
In prevention programs, a time lag always occurs between the intervention and any
effect on health outcomes. This time lag must be considered in conducting any analy-
sis, because decision makers prefer that benefits occur as soon as possible after a
program is implemented. This time preference is incorporated into BASICC by dis-
counting costs and effects that will occur in future years applied to the present. The
discount factor can be calculated directly or can be found in many finance or account-
ing books or on financial calculators. The formula for discounting a cost or a benefit
that will occur in the future (at time T) is as follows:
event or cost occurring in year T
(1 + discount rate) T
The recommended discount rate for BASICC is 3% (2 ) but is usually varied over a
reasonable range (e.g., 0 to 8%) in a sensitivity analysis.
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METHODS
The six data elements necessary for completing BASICC are as follows.
• A complete description of the program, the units in which the service(s) are pro-
vided, and the time frame of the program.
• Health outcome(s) averted by the prevention program and the estimated time be-
tween its implementation and when the health outcome is averted.
• The rates and societal burden of the health outcome.
• The preventable fraction for the health outcome, with the program in place and
used in a realistic manner (i.e., the proportion of the health outcome averted
through the program).
• Intervention costs per unit of intervention, including the cost of any intervention
side effects.
• Direct medical treatment cost of the health outcome prevented.
Net costs can be calculated from these six elements.
Description of the Program
A comprehensive description of a prevention program includes the following items
(12 ):
• a statement of the objectives; 
• a description of the target population; 
• a measure of effectiveness; 
• an understanding of external environmental constraints on program effectiveness;
• a list of resources required; 
• a method for day-to-day management of the program; 
• a mechanism for long-range planning and reaction to environmental changes; 
• the implementation strategy to be used for a new program or changes in a pro-
gram; and 
• evidence that the program benefits the participants (i.e., scientific evidence of ef-
fectiveness). 
A time frame for assessing the intervention and the health outcome must be se-
lected. A full year of cost (resource) data is suggested to compensate for any seasonal
variation.
Averted Health Outcomes
Prevention programs should a) improve the quality of life, b) reduce the incidence
or severity of a disease or injury, and c) reduce premature death through early detec-
tion or interventions to reduce risks or exposures associated with incidence. A
prevention program should have a specific objective: to avert or reduce the occur-
rence of a specific health outcome. Prevention effectiveness analyses are generally
incidence based; therefore, the analysis should include all adverse health outcomes
that are caused or prevented during the lifetime of the participant as a result of the
prevention program.
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Rates and Economic Burden of the Health Outcome
Information about the incidence and prevalence of the health outcome with and
without exposure to the prevention program should be summarized. The rate and
number of cases of the health outcome in the geographic area of interest by relevant
demographic and risk group provide an assessment of the magnitude of the problem
being prevented. The economic burden of the health outcome also should be summa-
rized and should be described in the context of the same demographic and risk
categories as the health outcome of interest.
Preventable Fraction
A prevention intervention is rarely 100% effective. Because the entire population at
risk may not be reached and because compliance among persons reached may not be
universal, programs generally do not work in practice in the same way that efficacy
studies or theoretical models predict. Thus, the preventable fraction of health out-
comes that will actually be averted by the intervention should be determined.
Formulas for calculating the preventable fraction may be found in the Guide (2 ). Alter-
natively, the following approximation for the preventable fraction may be used, in
which rate refers to the rate of the health outcome both with (designated as “I”) and
without (“O”) the intervention, the proportion (p) of the population reached, and the
proportion who comply.
Rate (I )  −  Rate (O )
Rate (O )
  ×  p (reached )  ×  p (who comply)
Intervention Resource Costs
Resources expended by prevention programs during a specified time period must
be defined and quantified by constructing an inventory of resources and their unit
costs. A detailed discussion of this may be found in the Guide (2 ) and elsewhere (13).
When a marginal analysis is considered, the program resources are determined from
a list such as the following:
• Variable costs:
– direct provider time by provider type for each type of service in intervention;
– supplies and materials for each type of service;
– laboratory or other tests for each type of service.
Costs to participants in the programs may include:
– time required of client for the intervention;
– expenses of client for the intervention.
• Fixed costs: 
– laboratory controls;
– development of new educational or promotional materials; 
– facilities, including rent and utilities specific to the intervention;
– equipment specific to the intervention;
– maintenance on facilities and equipment specific to the intervention; 
– administrative and support staff specific to the intervention;
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– other direct costs of providing services within intervention (e.g., travel, reused ma-
terials, and professional development).
The above list suggests types of resources that are used in most prevention pro-
grams and is not meant to be all inclusive.
Each item on the inventory has a unit cost (e.g., salary, fringe benefits per hour of
provider time, or price paid for a laboratory test or reimbursement rate per mile of
travel). In assessments such as the example that follows, those resources that are not
new or expanded are not included in this resource inventory.
The total cost of a prevention program is determined by summing the total variable
costs and the total fixed costs incurred by the program during the designated time
period. The total variable costs are obtained by multiplying the unit cost of each vari-
able input by the quantity used during the period and summing over all variable
inputs. The quantity of variable inputs used is a function of the level of output of the
program (e.g., the number of clients served). The total fixed costs are obtained by
multiplying the unit cost of each fixed input by the quantity used and summing over
all fixed inputs used. The quantity of fixed inputs (e.g., building rent) is independent of
the level of output of the program over the range of outputs under consideration.
Once the unit costs and fixed costs are determined for all resources during the time
period of interest, a summary table can be prepared. Included in the following exam-
ple are the resources (column A); their unit costs (column B); the quantity of the
resource used during the time period of interest (column C); and the total resource
cost ([column D] = [column B] X [column C]). By summing the values in column D, the
total cost of the intervention during the time period can be estimated.
For example, a 6-week group smoking-cessation program with 25 participants, re-
sources might include provider time for the intervention (i.e., class time and
preparation) and a brochure and progress calendar for each client. A room at a univer-
sity student center is rented specifically for this program. Participants attend six
45-minute classes and travel an average of 30 minutes per class (6 X 1.25 hours = 7.5
hours). The median wage in the area is $10 per hour. The client’s payment for the
program is not included because that would count the resources used twice: once
from the agency’s and once from the participant’s perspective. The societal perspec-
tive counts resource costs only once. 
In the resource inventory for this program (Table 1), the total cost of the resources
used is divided by the number of participants to calculate the cost per participant.
This calculation provides an estimate of the expected cost per participant in the
intervention. If a program anticipates that 1,500 persons will participate in this inter-
vention during the next year, the expected cost will be the cost per unit of intervention
multiplied by 1,500, in this case, $11.13 X 1,500 = $16,695. Including participant costs,
the expected cost for 1,500 participants is $86.13 X 1,500 = $129,195. Multiplying the
expected cost per participant by the expected number of participants provides an ac-
curate estimate only if the per-client fixed costs do not change as the program
expands. The inclusion of participant costs is necessary if the societal perspective is
taken. 
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Treatment Costs for the Health Outcome
For every health outcome averted, the direct costs associated with the health out-
come are also prevented. This benefit of the prevention intervention is accounted for
in the net cost calculation, which includes medical treatment costs and nonmedical
costs (e.g., household assistance or hospice costs) (2 ). 
For some health outcomes, medical treatment costs are available. For infectious
diseases or acute health conditions (e.g., injuries), the cost per episode is needed. For
chronic diseases (e.g., diabetes), the discounted lifetime cost or cost per person-year
is more useful. Nonmedical costs are often more difficult to determine.
The difference in rates of the health outcome both with and without the interven-
tion, as applied to the target population, is used to determine the number of cases of
the health outcome that are prevented. The cost per health outcome is then multiplied
by the number of cases averted to estimate the expected savings in treatment cost. 
THE CALCULATION OF NET COSTS
The net cost of the program can be calculated by using the six elements described
previously. Net cost can be summarized as the cost of the intervention and side effects
for 10
n
 persons minus the direct costs associated with the expected number of cases
averted in the same 10
n
 persons. The accuracy of this estimate depends on whether
the calculated per-unit fixed costs remain constant for this number of participants.
If the net cost is negative, then the savings associated with the health outcomes
prevented exceed the cost of the prevention program. Even if the net costs are posi-
tive, the public health reasons for the intervention may be compelling, particularly
given that productivity losses and intangible costs (e.g., changes in the quality of life
associated with the health outcome) have been excluded from the analysis. The deci-
sion to implement an intervention should be based on the value that participants and
society place on preventing the health condition, not on whether the intervention is
cost saving.
To continue the example on smoking cessation, an example of a net cost calcula-
tion follows (Table 2). 
TABLE 1. Example of a resource inventory
(A) (B) (C) (D) = (B) X (C)
Resource Unit cost No. units used Resource cost
Provider time $20 per hour 6 hours $120.00
Brochure $28 per 100 items 25 items $7.00
Calendar $0.05 per item 25 items $1.25
Room $25 per session 6 sessions $150.00
Participant $10 per hour 7.5 hours X 25 clients
per group $1875.00*
Total cost, excluding participant costs† $278.25
Total cost, including participant costs $2,153.25
*Cost per participant = $2,153.25 ÷ 25 participants = $86.13
†If participant costs are excluded, the cost per participant is $278.25 ÷ 25 participants = $11.13
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             Therefore,  the  net  cost  =  $86,130  −  $310,470  =  −$224,340
DISCUSSION
During 1992 and 1993, CDC published eight prevention effectiveness assessments
in the MMWR (3–10 ). These reports demonstrated an approach to prevention effec-
tiveness analyses that was based on information obtained from previously published
studies. Although each analysis followed the same general framework and content
guide, the information available for each analysis differed. As a result, each report
differed in format and content. The BASICC methodology provides a minimum stand-
ard approach for analyzing prevention strategies.
Several factors influence the cost effectiveness of a public health program. How a
program is implemented has a direct effect on cost. For example, a water fluoridation
program (3 ) is available to all persons, regardless of age, in a community that has a
common water supply. In 1989, approximately 135 million U.S. residents used water
that had adjusted or natural fluoride concentrations considered adequate for im-
proved dental health. However, persons who reside in rural areas and obtain their
drinking water from individual wells cannot be reached with a community-based pro-
gram. Thus, a program for municipal water supply fluoridation can only target
populations that have unfluoridated municipal water supplies.
The size of an intervention and the population exposed to the intervention can also
affect costs. For example, an infection-control program for a 1,000-bed hospital might
not be four times more expensive than one for a 250-bed hospital (5 ).
Measurements of an intervention effect might not be empirically based on the
population of interest. For example, tractor rollover protection data from agricultural
tractors (6 ) should not be expected to apply to garden tractors. In addition, extrapolat-
ing from one population to another should be done with caution (e.g., data concerning
2B. Example of a net cost calculation
For 1,000 persons: Cost calculations
Intervention costs $86,130
Cases of smoking-related disease averted 10 – 2 = 8
Medical costs of disease averted 8 X $55,000 = $440,000
Medical costs equally spaced and discounted,
3% per year, 24 years 0.7056 X $440,000 = $310,470
TABLE 2. Method for net cost calculation
2A. Information necessary for net cost calculation
Data Cost
Cost of intervention per participant $86.13
Hypothetical medical care costs per case of
smoking-related disease $55,000
Rate of smoking-related disease among
smokers who are not participants 10 cases per 1,000 smokers
Rate of disease among participants 2 cases per 1,000 nonsmokers
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use of bicycle helmets in Australia [9 ] might not reflect behaviors and expectations in
the United States).
An unforeseen effect of environmental changes could alter the estimated prevent-
able fraction. When the time period between the intervention and the benefit is short
and the environment is similar, the intervention will be more likely to have the desired
effect. For example, estimates of the effect of smoking cessation programs could be
influenced during the next decade by new federal excise tax policies and new treat-
ment technology.
A single adverse health outcome might be prevented by several different associ-
ated prevention programs. For example, risk for coronary heart disease is associated
with smoking, hypertension, hypercholesterolemia, low levels of physical activity,
and, in women, estrogen loss. The independent risk reduction attributed to a program
to increase physical activity is difficult to assess.
Some single interventions (e.g., vaccinations) occur a limited number of times per
lifetime; other interventions (e.g., water fluoridation and mammography screening)
are continual or are repeated many times during a person’s lifetime. The cost and
effect of 1 year of fluoridation or of one mammography screening may be misleading.
The analysis should compare the total lifetime costs for the prevention program—
rather than the costs for one application of the program—with the adverse health
outcomes averted as a result of the program. 
Prevention programs can take place in various settings and sites, including treat-
ment centers. For example, breast cancer screening costs (4 ) are variable. The total
cost of the technician and the radiologist fees, the use of the mammography screen-
ing device and materials, and the visit-associated administrative duties ranges from
less than $50 to several hundred dollars. An effective program can be simply a trans-
fer of resources and costs from one site to another. Results of BASICC analyses can
enable decision makers to deliver more health benefits from prevention services with
the limited resources available.
Health outcomes are inherently not comparable. For example, tractor rollover pro-
tection systems not only prevent death but also reduce the severity of nonfatal injuries
(6 ). In fact, most injuries are not fatal; fatal injuries, however, are more likely to be
reported than are nonfatal injuries. A common standard of measure, such as years of
healthy life gained (14,15 ), should be used to enhance comparability whenever possi-
ble to facilitate comparison across interventions for different health outcomes. All
resource costs should be included when different intervention strategies are com-
pared.
Currently, most resources are allocated for the prevention of health outcomes with-
out the use of a standard methodology and without an answer to the two questions:
“what works?” and “how much does it cost?” The BASICC methodology for preven-
tion effectiveness provides a minimum standard approach for a more rational
allocation of resources and for more informed decision making.
In Memoriam
Robin Gorsky, who was instrumental in bringing the principles of operations research and
cost-effectiveness analysis to public health, died before this report went to press. She was a
strong supporter and friend of CDC.
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